参考文献/References:
[1] ZHAO Hailin, ALAM A, SOO A P, et al. Ischemia-reperfusion injury reduces long term renal graft survival: mechanism and beyond[J] .EBio Medicine, 2018 , 28:31-42.
[2] DUFFIELD J S. Cellular and molecular mechanisms in kidney fibrosis[J]. J Clin Inves, 2014 , 124(6):2299-2306. ,
[3] FENG Ye, REN Jiafa, GUI Yuan, et al. Wnt/β-catenin-promoted macrophage alternative activation contributes to kidney fibrosis[J]. J Am Soc Nephrol, 2018, 29 (1):182-193.
[4] CERNOCH M, VIKLICKY O. Complement in kidney transplantation[J]. Front Med (Lausanne), 2017, 4:66.
[5] CHOUDHRY N, LI Ke, ZHANG Ting, et al. The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis[J]. Kidney Int, 2016, 90(3):540-554.
[6] BAO Xue, BORN? Y, MUHAMMAD I F, et al. Complement C3 and incident hospitalization due to chronic kidney disease: a population-based cohort study[J].BMC Nephrol, 2019, 20(1):61.
[7] LAURA R, ALBERTO O. Timing of eculizumab therapy for C3 glomerulonephritis[J]. Clinical Kidney Journal, 2015, 8(4): 449-452.
[8] 饶斯逸 , 张晶 , 崔炯 , 等 .补体 C3参与小鼠缺血再灌注急性肾损伤后肾脏炎症及慢性纤维化 [J].中华高血压杂志 ,2022,30(2):145-152. RAO Siyi, ZHANG Jing, CUI Jiong, et al.Comple-ment C3 participates in inflammation and post-injury fibrosis in mice with ischemia-reperfusion induced acute kidney injury[J]. Chinese Journal of Hyperten-sion,2022,30(2):145-152.
[9] LIU Fang, GOU Rong. HUANG Jun. et al Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro[J]. Chin Med J (Engl), 2011, 124(23):4039-4045.
[10] PENG Qi, WU Weiju, WU Kunyi, et al. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury[J]. Kidney Int, 2019, 96(1):117-128.
[11] CHMILEWSKY F, ABOUT I, CHUNG S H. Pulp fibroblasts control nerve regeneration through complement activation[J]. J Dent Res, 2016 , 95(8):913-922.
[12] 肖广智 , 高旋 , 丁进.血清补体 C3,C4 水平正常的活动性狼疮性肾炎患者的临床特征与实验室相关指标分析 [J].现代检验医学杂志 , 2022, 37(5): 39-43. XIAO Guangzhi, GAO Xuan, DING Jin.Analysis of clinical and laboratory characteristics of the patients of active lupus nephritis with normal levels of serum complement C3 and C4[J]. Journal of Modern Laboratory Medicine, 2022, 37(5): 39-43.
[13] HU Chao, LI Long, DING Peipei, et al.Complement inhibitor CRIg/FH ameliorates renal ischemia reperfusion injury via activation of PI3K/AKT signaling[J]. J Immunol,2018,201(12):3717-3730.
[14] CHEN Wei , YUAN Hui , CAO Wenmin , et al. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation[J]. Theranostics, 2019, 9(14):3980-3991
[15] LIU Ziming,ZHU Shiming,QIN Xiangjing, et al.Silencing of C5a receptor gene with siRNA for protection from Gram-negative bacterial lipopolysaccharide-induced vascular permeability[J]. Mol Immunol,2010 ,47(6):1325-1333.